CTIS.eu › Cities › Netherlands › Leiden
Leiden
Netherlands
450 total trials
216 recruiting
2024-514991-41-01
4
Upper Tract Urothelial Carcinoma. Upper urinary tract transitional cel
2022-501006-34-00
5
Liver cirrhosis
2024-514693-47-00
11
EGFR mutated locally advanced or metastatic non-small cell lung cancer
2024-519587-40-00
7
Parkinson’s Disease with at Least One GBA1 Mutation
2023-509675-16-01
5
All patients who receive ECMO treatment during the study period in one
2023-510312-40-00
6
Secondary hyperparathyroidism
2024-510617-15-00
5
Non-metastatic resectable pancreatic cancer
2024-511656-41-00
4
Duchenne Muscular Dystrophy
2024-512850-10-00
5
Resectable colorectal rectal metastases without extrahepatic disease
2024-512975-11-01
11
urothelial cancer
2024-515312-50-00
6
Systemic sclerosis
2024-515900-38-00
7
B-cell Acute Lymphoblastic Leukemia
2024-516126-54-00
4
ANAPLASTIC THYROID CANCER
2024-516127-14-01
7
metastasized melonama uveal
2024-517127-40-00
11
Migraine
2024-517310-15-00
3
Parkinson's Disease
2024-517485-42-00
5
Non-psychotic therapy resistant unipolar depression
2024-517939-53-00
1
Respiratory tract diseases
2024-519786-22-01
9
metastatic non-small cell lung cancer (NSCLC)
2025-520554-11-00
5
Cardiovascular Disease
2025-520792-67-00
5
Patients with advanced, metastatic NSCLC that have not progressed on a
2025-521113-13-00
10
Early Parkinson’s Disease
2025-522659-24-00
9
Ovarian carcinoma
2025-522694-11-00
6
Episodic expiratory wheezing
Showing 1–24 of 450 trials